Market Tracker

03/24 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

14.89
Delayed Data
As of Mar 24
 +0.05 / +0.34%
Today’s Change
12.25
Today|||52-Week Range
27.02
-17.37%
Year-to-Date
CFO Says Depomed to Buy or Be Sold
Mar 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close14.84
Today’s open14.84
Day’s range14.75 - 15.09
Volume495,922
Average volume (3 months)1,415,191
Market cap$924.7M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)+67.24%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book3.68

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-1.46-3.61%
INSMInsmed Inc+0.16+1.02%
FLXNFlexion Therapeutics...+1.02+3.89%
SGYPSynergy Pharmaceutic...+0.10+2.24%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts